SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-177056
Filing Date
2015-05-07
Accepted
2015-05-07 16:01:53
Documents
8
Period of Report
2015-06-16
Effectiveness Date
2015-05-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A d904982ddef14a.htm DEF 14A 274210
2 GRAPHIC g904982g50i50.jpg GRAPHIC 28781
3 GRAPHIC g904982pc_pg001a.jpg GRAPHIC 4420
4 GRAPHIC g904982pc_pg001b.jpg GRAPHIC 6140
5 GRAPHIC g904982pc_pg002a.jpg GRAPHIC 4799
6 GRAPHIC g904982pc_pg002b.jpg GRAPHIC 827
7 GRAPHIC g904982pc_pg002c.jpg GRAPHIC 1069
8 GRAPHIC g904982pc_pg002d.jpg GRAPHIC 1024
  Complete submission text file 0001193125-15-177056.txt   341188
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36296 | Film No.: 15841631
SIC: 2834 Pharmaceutical Preparations